Second Lawsuit Filed Against FDA for Failure to Ban Menthol Tobacco

Regulations by 2FIRSTS.ai
Apr.03.2024
Second Lawsuit Filed Against FDA for Failure to Ban Menthol Tobacco
Public health organization sues US regulators for delaying ban on mint tobacco products, putting lives at risk.

According to a report by Bloomberg on April 2nd, the American public health organization has filed a second lawsuit against US regulatory agencies for failing to implement a plan to ban the sale of menthol tobacco products on time. The lawsuit, filed on Tuesday, alleges that the Food and Drug Administration (FDA) unlawfully and unreasonably delayed life-saving regulations.

 

According to Phillip Gardiner, co-chair of the African American Tobacco Control Leadership Council, the FDA has repeatedly failed to take action against menthol tobacco within the specified deadlines. A representative from the organization, which is suing the FDA, stated, "If past behavior is any indication of future performance, then they will once again sit on the sidelines."

 

Data from the Centers for Disease Control and Prevention (CDC) show that between 1980 and 2018, over 10 million Americans began smoking due to menthol cigarettes, and approximately 378,000 people died prematurely. Menthol cigarettes are particularly popular among African American smokers, largely due to aggressive marketing by tobacco companies in black communities and sponsorship of events like jazz concerts. In the United States, about 40% of the cases of premature death caused by menthol cigarette use are among African Americans.

 

The public health organization had previously filed a lawsuit against the FDA in 2020 for its inaction, but the lawsuit was dismissed when the FDA announced two proposed regulations to ban the sale of menthol cigarettes and flavored cigars in April 2022.

 

However, the FDA has delayed the final ruling on menthol tobacco until August 2023, then again in December, and then rescheduled it for March 2024. Kelsey Romeo-Stuppy, an attorney for one of the organizations dedicated to fighting smoking and promoting health, stated, "The FDA no longer has any procedural reason not to pass this regulation."

 

The lawsuit alleges that the FDA's inaction on menthol tobacco is consistent with its pattern of behavior when faced with public health risks, including delays in action on opioid crisis and contaminated baby formula issues. The global market for tobacco companies is facing a decrease in menthol sales, with the EU banning sales of menthol tobacco since 2020 and Canada since 2017. In the US, California, Massachusetts, and dozens of counties have also implemented local bans on menthol.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

French Anti-Tobacco Group Questions PMI’s IQOS “Curiosity” Campaign Over Potential Youth Appeal
French Anti-Tobacco Group Questions PMI’s IQOS “Curiosity” Campaign Over Potential Youth Appeal
According to French anti-tobacco group Générations Sans Tabac, Philip Morris International’s (PMI) IQOS “Curiosity” campaign has drawn attention from public health advocates. The group argues that the campaign uses themes including curiosity, exploration and lifestyle branding that could increase interest among younger audiences. PMI has positioned IQOS as a key part of its smoke-free product strategy, while France maintains strict restrictions on tobacco and nicotine product marketing. The debate highlights ongoing tensions between heated tobacco branding strategies and public health concerns in Europe.
Jul.24
Product | PMI Japan Launches SENTIA Passion Fruit Capsule, Expanding the IQOS ILUMA Flavor Portfolio
Product | PMI Japan Launches SENTIA Passion Fruit Capsule, Expanding the IQOS ILUMA Flavor Portfolio
Philip Morris Japan (PM Japan) has introduced SENTIA Passion Fruit Capsule, a new tobacco stick designed for the IQOS ILUMA heated tobacco platform. Featuring a crush-activated capsule, the product combines menthol with passion fruit flavor to provide an additional flavor experience. The product launched in Japan from August 3, 2026, through IQOS official channels, convenience stores and tobacco retailers.
Aug.04
Putin Signs Russia’s Tobacco and Nicotine Product Licensing Law, Banning Unlicensed Sales From 2027
Putin Signs Russia’s Tobacco and Nicotine Product Licensing Law, Banning Unlicensed Sales From 2027
Russian President Vladimir Putin has signed a law introducing mandatory licensing for wholesale and retail trade in tobacco and nicotine-containing products, with the system taking effect on October 1, 2026, and unlicensed operations banned from March 1, 2027, while vape and e-liquid retail may also face uncertainty from temporary regional sales-ban powers.
Jul.01
Nevada Considers Nearly Doubling Tobacco Taxes, With $65 Million in New Revenue Expected From Expanded Nicotine Levies
Nevada Considers Nearly Doubling Tobacco Taxes, With $65 Million in New Revenue Expected From Expanded Nicotine Levies
Health groups in Nevada are urging lawmakers to nearly double the state cigarette tax and extend similar tax changes to other nicotine products, including e-cigarettes and nicotine pouches.
Jul.17
Illicit Vape and Nicotine Pouch Seizures Concentrated in UK Hotspots, New Data Shows
Illicit Vape and Nicotine Pouch Seizures Concentrated in UK Hotspots, New Data Shows
Freedom of Information (FOI) data from the UK shows that more than 3,000 seizures of illegal nicotine products were recorded in the 2024/25 financial year, with Hull, Liverpool and Bolton emerging as the most active enforcement hotspots — highlighting that the problem of illicit vapes, nicotine pouches and smokeless tobacco products persists across many parts of the country.
Jun.16
Ohio Supreme Court Weighs Whether State Consumer Law Can Restrict Flavored Vape Sales
Ohio Supreme Court Weighs Whether State Consumer Law Can Restrict Flavored Vape Sales
The Ohio Supreme Court is hearing a case involving flavored vape sales and whether state authorities can use consumer protection laws to take action against retailers selling unauthorized vape products. Ohio officials argue that selling unauthorized flavored vapes may constitute consumer deception, while retailers argue that tobacco product regulation falls under federal Food and Drug Administration (FDA) authority and that states cannot impose additional restrictions through consumer laws. The case could affect the scope of state-level vape regulation across the United States.
Aug.06